Morning Overview on MSN
A new two-pill combo just slashed LDL cholesterol by 48.6% in a phase 3 trial — the sharpest drop ever logged without adding a statin to the mix
For the roughly 30 million American adults who have been told their cholesterol is too high but cannot stomach a statin, the ...
Drugmaker Eli Lilly is testing a new experimental drug that could be a game changer in treating high cholesterol, it said.
A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...
If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...
An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...
A new kind of pill sharply reduced artery-clogging cholesterol in people who remain at high risk of heart attacks despite taking statins, researchers reported Wednesday. It’s still experimental but ...
High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...
One and done? Pharma giant Eli Lilly announced Monday that its gene-editing therapy can reduce LDL (“bad”) cholesterol by up ...
Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results